Pharma Journalist -

Kymera Therapeutics, Inc. a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced…
Read More...

Valneva SE and IDT Biologika announced their collaboration for the production of Valneva’s inactivated COVID-19 vaccine candidate VLA2001. This follows last week’s announcement that…
Read More...

Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system,…
Read More...

Thermo Fisher Scientific Inc. confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of…
Read More...

Avacta Group plc a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and pre|CISION platforms, is…
Read More...

Blueprint Medicines Corporation announced that the company has entered into a definitive agreement under which it will acquire Lengo Therapeutics, a privately held precision oncology…
Read More...

SMi Reports: SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK. The 10th…
Read More...

The Iceland based healthcare investor, Aztiq (“Aztiq”), founded by Alvogen’s Chairman and CEO, Róbert Wessman and Innobic Asia (“Innobic”), a wholly-owned Life Science arm of PTT Public…
Read More...

Enzychem Lifesciences and Cadila Healthcare Ltd, a part of the Zydus Group, announced that they have entered a Manufacturing License and Technology Transfer Agreement for the world’s…
Read More...

SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for…
Read More...